In this prospective, multicenter cohort study, patients with AF who were receiving factor Xa inhibitors and undergoing procedures with minimal to low bleeding risk had low rates of major bleeding and thromboembolism when following the standardized PERIXa protocol for perioperative management. This evidence concerns the gene F10 and atrial fibrillation.